Group 1: Netflix - Netflix has been a core holding and recently saw a price dip, which presents a buying opportunity around the $75 range [2][3] - The company is expected to walk away from a merger deal with Warner Brothers, which is viewed as a positive move that will enhance its competitive position in Hollywood [4] - The stock is anticipated to recover to around $125 as Netflix continues to dominate the market [4] Group 2: Eli Lilly - Eli Lilly is highly regarded for its GLP-1 drugs, with an upcoming approval for a new pill that is expected to be more effective than competitors [5][6] - The company is positioned to dominate the weight loss drug market, especially with the introduction of GLP-3 next year [7][8] - Eli Lilly is seen as having superior management and products compared to its main competitor, Novo Nordisk [8] Group 3: Micron and Nvidia - Micron shares have increased over 40% in 2026, but there is a belief that the stock is still undervalued due to market doubts about AI growth [9][10] - Micron's earnings are projected to rise significantly, with estimates suggesting earnings could reach over $30 per share, indicating a strong upside potential [10][11] - Nvidia is also viewed as undervalued, trading at a low multiple compared to its historical average, presenting a significant investment opportunity [12][13] Group 4: Tesla - Tesla is currently facing challenges, with a noted lack of focus on its EV business and a shift towards battery storage as its standout segment [15][16] - The company's future reliance on autonomous vehicle technology is questioned, with concerns about its economic viability [17][18] - The stock is perceived to be overvalued, with a suggested fair value around $200, indicating a tough investment outlook [18]
4 Stocks To Buy While Everyone Else Doubts AI